Abstract

BackgroundTo evaluate the efficacy of Ahmed Glaucoma Valve (AGV) surgery and the optimal interval between penetrating keratoplasty (PKP) and AGV implantation in a population of Asian patients with preexisting glaucoma who underwent PKP.Methodology/Principal FindingsIn total, 45 eyes of 45 patients were included in this retrospective chart review. The final intraocular pressures (IOPs), graft survival rate, and changes in visual acuity were assessed to evaluate the outcomes of AGV implantations in eyes in which AGV implantation occurred within 1 month of post-PKP IOP elevation (Group 1) and in eyes in which AGV implantation took place more than 1 month after the post-PKP IOP evaluation (Group 2). Factors that were associated with graft failure were analyzed, and the overall patterns of complications were reviewed. By their final follow-up visits, 58% of the patients had been successfully treated for glaucoma. After the operation, there were no statistically significant differences between the groups with respect to graft survival (p = 0.98), but significant differences for IOP control (p = 0.049) and the maintenance of visual acuity (VA) (p<0.05) were observed. One year after surgery, the success rates of IOP control in Group 1 and Group 2 were 80% and 46.7%, respectively, and these rates fell to 70% and 37.3%, respectively, by 2 years. Factors that were associated with a high risk of AGV failure were a diagnosis of preexisting angle-closure glaucoma, a history of previous PKP, and a preoperative IOP that was >21 mm Hg. The most common surgical complication, aside from graft failure, was hyphema.Conclusions/SignificanceEarly AGV implantation results in a higher probability of AGV survival and a better VA outcome without increasing the risk of corneal graft failure as a result of post-PKP glaucoma drainage tube implantation.

Highlights

  • The presence of glaucoma following a penetrating keratoplasty (PKP) procedure is the second most common cause of corneal graft failure [1]

  • There is no consensus regarding the amount of time between PKP and Ahmed Glaucoma Valve (AGV) implantation that is optimal for controlling intraocular pressures (IOPs), improving graft survival, and preserving visual acuity (VA) in patients with preexisting glaucoma

  • Ahmed glaucoma valve implantation often enables the successful control of refractory glaucoma in cases in which other surgical modalities are ineffective [7,8,9,10,11,12]

Read more

Summary

Introduction

The presence of glaucoma following a penetrating keratoplasty (PKP) procedure is the second most common cause of corneal graft failure [1]. Several reports have shown that using GDDs as a method of treating glaucoma, as is the case with Ahmed valve (AGV) implantation, is an effective method of controlling intraocular pressure (IOP) in glaucoma patients. There is no consensus regarding the amount of time between PKP and AGV implantation that is optimal for controlling IOP, improving graft survival, and preserving VA in patients with preexisting glaucoma. There have been no studies that compare the surgical outcomes of patients who received AGV implantations at various intervals after undergoing PKPs. To evaluate the efficacy of Ahmed Glaucoma Valve (AGV) surgery and the optimal interval between penetrating keratoplasty (PKP) and AGV implantation in a population of Asian patients with preexisting glaucoma who underwent PKP

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.